Hüseyin AYDIN, Ayşe AYDINOĞLU, Müge ATAR, Mustafa AKÇAM, Özgür PİRGON

Non-Alkolik Yağlı Karaciğer Hastalığı Olan ve Olmayan Obez Çocuklarda Hepatik Vasküler Akım Değişikliklerinin Değerlendirilmesi

Amaç: Non-alkolik yağlı karaciğer hastalığı olan ve olmayan obez çocuklarda hepatik vasküler akım değişikliklerini Doppler ultrason ile değerlendirmektir.

Anahtar Kelimeler:

Non alkolik yağlı karaciğer hastalığı, portal ven, hepatik arter, Doppler ultrasonografi

EVALUATION OF HEPATIC VASCULAR FLOW ALTERATIONS IN OBESE CHILDREN WITH AND WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE

Objective: To evaluate hepatic vascular flow alterations using Doppler ultrasound in obese children with and without non-alcoholic fatty liver disease.

Keywords:

Non-alcoholic fatty liver disease, portal vein, hepatic artery, Doppler ultrasound,

PDF

___

1. Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908-22.
2. Akcam M, Boyaci A, Pirgon O, Koroglu M, Dundar BN. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. Clin Imaging. 2013;37(3):504-8.
3. Mosca A, Panera N, Crudele A, Alisi A. Noninvasive diagnostic tools for pediatric NAFLD: where are we now? Expert Rev Gastroenterol Hepatol. 2020:14(11):1035-46.
4. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038-48.
5. Francque S, Laleman W, Verbeke L, Van Steenkiste C, Casteleyn C, Kwanten W et al. Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture. Lab Investig. 2012;92(10):1428-39.
6. Francque S, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P et al. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur J Gastroenterol Hepatol. 2010;22(12):1449-57.
7. van der Graaff D, Kwanten WJ, Francque SM. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. Med Hypotheses. 2019;122:188-97.
8. Lautt WW. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res. 2007;37(11):891-903.
9. Balasubramanian P, Boopathy V, Govindasamy E, Venkatesh BP. Assessment of portal venous and hepatic artery haemodynamic variation in non-alcoholic fatty liver disease (NAFLD) patients. J Clin Diagnostic Res. 2016;10(8):TC07.
10. Soresi M, Giannitrapani L, Noto D, Terranova A, Campagna ME, Cefalù AB et al. Effects of steatosis on hepatic hemodynamics in patients with metabolic syndrome. Ultrasound Med Biol. 2015;41(6):1545-52.
11. Hizli S, Koçyigit A, Arslan N, Tuncel SA, Demircioglu F, Cakmakçi H et al. Hepatic artery resistance in children with obesity and fatty liver. Indian J Pediatr. 2010;77(4):407-11.
12. Mohammadi A, Ghasemi-Rad M, Zahedi H, Toldi G, Alinia T. Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. Med Ultrason. 2011;13(3):200-6.
13. Tarzamni MK, Khoshbaten M, Sadrarhami S, Daneshpajouhnejad P, Jalili J, Gholamian M et al. Hepatic artery and portal vein doppler indexes in non-alcoholic fatty liver disease before and after treatment to prevent unnecessary health care costs. Int J Prev Med. 2014;5(4):472-7.
14. Ezaizi Y, Kabbany MN, Selvakumar PKC, Sarmini MT, Singh A, Lopez R et al. Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents. JHEP Reports. 2019;1(4):259-64.
15. Suri A, Song E, van Nispen J, Voigt M, Armstrong A, Murali V et al. Advances in the epidemiology, diagnosis, and management of pediatric fatty liver disease. Clin Ther. 2021;43(3):438-54.
16. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I et al. Prevalence of fatty liver in Japanese children and relationship to obesity. Dig Dis Sci. 1995;40(9):2002-9.
17. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138(4):1357-64,1364.e1-2.
18. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999–2004. Gastroenterology. 2007;133(6):1814-20.
19. Ferraioli G, Wong VW-S, Castera L, Berzigotti A, Sporea I, Dietrich CF et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419-40.
20. Choi SH, Kwon JH, Kim KW, Jang HY, Kim JH, Kwon H et al. Measurement of liver volumes by portal vein flow by Doppler ultrasound in living donor liver transplantation. Clin Transplant. 2017;31(9):e13050.
21. Kim SH, Choi MS, Kim MJ, Kim YH, Cho SH. Role of semi–quantitative dynamic contrast–enhanced MR imaging in characterization and grading of prostate cancer. Eur J Radiol. 2017;94:154-9.
22. Zhang L, Duan YY, Li JM, Yin JK. Hemodynamic features of Doppler ultrasonography in patients with portal hypertension: intraoperative direct measurement of portal pressure in the portal venous system. J Ultrasound Med. 2007;26(12):1689-96.
23. Rocha HLOG, Diniz ALD, Borges VF de A e, Salomão FC. Assessment of portal venous index as a non-invasive method for diagnosing liver fibrosis in patients with chronic hepatitis C. Arq Gastroenterol. 2012;49(1):14-8.
24. Belotta AF, Teixeira CR, Padovani CR, Rahal SC, Mayer MN, Mamprim MJ. Sonographic evaluation of liver hemodynamic indices in overweight and obese dogs. J Vet Intern Med. 2018;32(1):181-7.
25. ML GDRM, Ferreira De Almeida EB V, Machado De Alcântara T, Borges De Araújo L, De Fátima Pinheiro C. Liver hemodynamic patterns in nonalcoholic steatosis: Doppler ultrasonography and histological evaluation. Minerva Gastroenterol Dietol. 2016;62(1):19-29.
26. Singh SP, Barik RK. Noninvasive biomarkers in nonalcoholic fatty liver disease: Are we there yet? J Clin Exp Hepatol. 2020;10(1):88-98.
27. Draijer LG, Feddouli S, Bohte AE, Rijcken THP, Benninga MA, Stoker J, et al. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease. Eur J Pediatr. 2019;178(6):863-70.
28. Tana C, Tana M, Rossi S, Silingardi M, Schiavone C. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. J Ultrasound. 2016;9(3):183-9.
29. Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 2008;12(4):733-46.
30. Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, Kohli R et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319-34.